Litcius/Paper detail

Personalized Multitarget Biologic Injection in the Spine: Prospective Case Series of Multitarget Platelet-Rich Plasma for Low Back Pain

Edilson Silva Machado, Mary A. Ambach, José Manuel Peixoto Caldas, Jason J Wei, Markus Bredemeier

2021Regenerative Medicine10 citationsDOI

Abstract

Aim: To evaluate the use of a multitarget platelet-rich plasma (PRP) injection approach for the treatment of chronic low back pain (LBP). Materials & Methods: Forty-six patients with more than 12 weeks of LBP who failed conservative treatments were injected with PRP into the facet joints, intervertebral discs, epidural space and/or paravertebral muscles. Visual analog pain scale and Roland-Morris Disability Questionnaire scores were measured at baseline and predefined intervals. Results: Mean visual analog pain scale was reduced from 8.48 to 5.17 and mean Roland-Morris Disability Questionnaire from 18.0 to 10.98 at 12 weeks (p < 0.001). These statistically significant improvements were sustained over 52 weeks. No adverse effects were observed. Conclusion: Our PRP approach demonstrated clinically favorable results and may be a promising treatment for chronic LBP.

Topics & Concepts

MedicineVisual analogue scalePlatelet-rich plasmaLow back painAdverse effectChronic painBack painPhysical therapyAnesthesiaPlateletInternal medicineAlternative medicinePathologyMusculoskeletal pain and rehabilitationSpine and Intervertebral Disc PathologyShoulder Injury and Treatment
Personalized Multitarget Biologic Injection in the Spine: Prospective Case Series of Multitarget Platelet-Rich Plasma for Low Back Pain | Litcius